Exits

EpiTherapeutics

Discovery of new pharmaceuticals for the treatment of cancer within the field of epigenetics.

Invested: 2010

Sold to Gilead in 2015

Lundbeckfonden Emerge

Nyheder

Dermtreat sikrer GMP-produktion
4. september 2017
Lundbeckfonden investerer i CRISPR-teknologi til redigering af bakteriers gener
25. august 2017
Lundbeckfonden investerer i banebrydende dansk mundhuleplaster
8. maj 2017